Bioethics in the Grocery-Store Checkout Line
By Ruth Graham,
The Atlantic
| 09. 15. 2015
It was a typical tabloid story with a highly atypical ending. In 2012, the actress Sofia Vergara became engaged to an entrepreneur named Nick Loeb while celebrating her 40th birthday at a resort in Mexico. It later emerged that the couple had created several embryos in 2013 using her eggs and his sperm, to be used for in vitro fertilization—but they broke up shortly afterwards, and Vergara was no longer interested in bringing the frozen embryos to term. Then came the twist: Last year, Loeb sued his ex-fiance to prevent her from destroying the two remaining embryos.
A custody dispute over two microscopic groups of cells—“our girls,” as Loeb calls them—is unusual. But messy, complex situations involving stars’ fertility are increasingly common. If you don’t follow celebrity gossip, you might have missed just how often stories about reproductive technology are gracing the covers of tabloid magazines. In recent years, these publications have become a window into the future of reproduction.
As recently as a decade ago, magazines handled stories about surrogacy and in-vitro fertilization like the relative novelty they...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...